United Therapeutics CorpAdd to My Watchlist

UTHR:USNASDAQ GSIndustry: Medical-Biomedical/Gene
  • 93.29
    Last
  • 4.92  -5.01%
    Today's Change
  • 98.21
    Previous Close
  • Today
     
    70.34
    116.65
    52 Week Low - High
5:20 pm ET 7/30/2014
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding47 million
Market Cap$4 billion
Return on Equity ttm23.20%
Last DividendUTHR:US does not pay a dividend
Earnings
EPS: Year Actual ttm5.100
EPS: Year Est. 12/14 ttm9.318
 
EPS: Quarterly Actual 6/14 2.30
EPS: Quarterly Est. 9/14 2.48
 
Price/Earnings ttm18.29
Relative Price/Earnings1.018
Earnings Growth Rate-40.24
Company Description
United Therapeutics Corporation develops pharmaceuticals to treat vascular diseases such as pulmonary hypertension and peripheral vascular disease. The Company's lead products are stable synthetic forms of prostacyclin and are delivered orally or subcutaneously.
Revenue$1 billion
Net Income$175 million
Total Assets$2 billion
Employees706
Web Sitewww.unither.com

Latest Headlines

Watchlist

Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

Sign In Now

 

Not Registered?

Get complete access to The Washington Post online - it's FREE!